BiomX Inc. (PHGE)
AMEX·Healthcare·Biotechnology
$0.88
-13.66%
Mkt Cap $11.82M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 24, 2026 | — | — | — | -$4.61 | -$4.61 | +0.00% | — | — |
| Q4 2025 Nov 12, 2025 | — | — | — | -$6.08 | -$5.51 | +9.38% | — | — |
| Q3 2025 Aug 13, 2025 | — | — | — | -$0.33 | $0.19 | +157.58% | — | — |
| Q2 2025 May 15, 2025 | — | — | — | -$0.42 | -$0.33 | +21.43% | — | — |
| Q1 2025 Mar 25, 2025 | — | — | — | -$1.65 | -$1.07 | +35.15% | — | — |
| Q4 2024 Nov 14, 2024 | — | -$84.00K | — | -$0.60 | -$0.97 | -61.67% | — | — |
| Q3 2024 Aug 14, 2024 | — | — | — | -$1.20 | $0.70 | +158.33% | — | — |
| Q2 2024 May 20, 2024 | — | -$88.00K | — | -$0.70 | -$1.50 | -114.29% | — | — |
| Q2 2024 Apr 3, 2024 | — | -$87.00K | — | -$1.10 | -$0.80 | +27.27% | — | — |
| Q4 2023 Nov 14, 2023 | — | -$89.00K | — | -$1.10 | -$1.30 | -18.18% | — | — |
| Q3 2023 Aug 9, 2023 | — | -$90.00K | — | -$1.20 | -$1.20 | +0.00% | — | — |
| Q2 2023 May 15, 2023 | — | -$91.00K | — | -$2.00 | -$2.00 | +0.00% | — | — |
| Q1 2023 Mar 29, 2023 | — | — | — | -$2.50 | -$2.00 | +20.00% | — | — |
| Q4 2022 Nov 9, 2022 | — | — | — | -$2.40 | -$2.30 | +4.17% | — | — |
| Q3 2022 Aug 10, 2022 | — | — | — | -$2.90 | -$2.50 | +13.79% | — | — |
| Q2 2022 May 11, 2022 | — | — | — | -$3.20 | -$2.70 | +15.63% | — | — |
| Q1 2022 Mar 30, 2022 | — | — | — | -$0.28 | -$3.60 | -1174.34% | — | — |
| Q4 2021 Nov 15, 2021 | — | — | — | -$2.50 | -$3.70 | -48.00% | — | — |
| Q3 2021 Aug 16, 2021 | — | — | — | -$3.70 | -$3.00 | +18.92% | — | — |
| Q2 2021 May 24, 2021 | — | — | — | -$3.80 | -$3.50 | +7.89% | — | — |